Logo-apb
Adv Pharm Bull. 2023;13(2): 350-360. doi: 10.34172/apb.2023.021
PMID: 37342375        PMCID: PMC10278222

Research Article

Restoring the Angiogenic Capacity of the Human Diabetic Adipose-derived mesenchymal stem cells Primed with Deferoxamine as a Hypoxia Mimetic Agent: Role of HIF-1α

Raziye Tajali 1 ORCID, Akram Eidi 1, Hosein Ahmadi Tafti 2, Abdolreza Pazouki 3, Ali Mohammad Sharifi 4,5,6 * ORCID

Cited by CrossRef: 2


1- Zeinhom A, Fadallah S, Mahmoud M. Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives. Stem Cell Res Ther. 2024;15(1) [Crossref]